What is actually involved in taking an
advanced therapy medicinal product
(ATMP) from a brilliant idea in the lab to
a successful product on the market? Is it
similar to the development of a combination
product? Or a monoclonal antibody?
Just how difficult can it be? The level of
activity surrounding ATMPs has been increasing,
with some remarkable therapeutic
opportunities currently being explored.